Chart review of records of patients treated for betel nut-induced oral cancer with pembrolizumab and cetuximab.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Objective Response Rate (ORR)
Timeframe: From date first treatment received until 3 months later